Thulium laser enucleation of the prostate in patients with large benign prostate hyperplasia and acute urinary retention

Nikolay Yu. Kostenkov , Salman Kh. Al-Shukri , Evgeniy S. Nevirovich , Oleg M. Mosiychuk , Igor V. Kuzmin , Ilia N. Tkachuk

Urology reports (St. - Petersburg) ›› 2023, Vol. 13 ›› Issue (2) : 109 -115.

PDF (924KB)
Urology reports (St. - Petersburg) ›› 2023, Vol. 13 ›› Issue (2) :109 -115. DOI: 10.17816/uroved501787
Original study
research-article
Thulium laser enucleation of the prostate in patients with large benign prostate hyperplasia and acute urinary retention
Author information +
History +
PDF (924KB)

Abstract

BACKGROUND: Benign prostatic hyperplasia is the most common urological disease in older men, leading to the development of bladder outlet obstruction and a decrease in the quality of life of patients. The choice of the method of surgical treatment of benign prostatic hyperplasia with large prostate volumes is the subject of discussion. There is also no unified approach to the management of patients with acute urinary retention due to benign prostatic hyperplasia.

AIM: To evaluate the results of thulium laser enucleation of the prostate in patients with large benign prostatic hyperplasia associated with acute urinary retention.

MATERIALS AND METHODS: The present study included the results of treatment of 237 patients with benign prostatic hyperplasia with a prostate volume of more than 80 cm3, of which 97 were hospitalized in the urology department for acute urinary retention. The age of the patients ranged from 51 to 89 years (average 70.2 years). The volume of the prostate gland ranged from 80 to 150 cm3 (mean 128.3 cm3). The control examination was performed on the 2nd day, as well as 3, 6 and 12 months after the surgery.

RESULTS: Surgical intervention was performed using a thulium fiber laser device FiberLase U1 (IRE-Polyus, Russia) with a power of 120 W. The time of surgery ranged from 63 to 127 minutes (average 74.3 minutes). The irrigation system was turned off on the 1st day of the postoperative period. The duration of urethral catheterization averaged 2.7 days. None of the patients in the study required blood transfusion or repeated surgery to coagulate the vessels of the prostate bed. After removal of the urethral catheter, all patients urinated on the first attempt. In 7 patients (2.95%), after removal of the urethral catheter, urinary incontinence was observed, during the first 6 months after the operation, urinary retention was restored in all of them. We did not note significant differences during the intra-, early and late postoperative period in operated BPH patients with and without acute urinary retention.

CONCLUSIONS: ThuLEP is an effective and safe method of surgical treatment of patients with benign prostatic hyperplasia with a prostate volume of more than 80 cm3, complicated by acute urinary retention.

Keywords

thulium laser / prostate enucleation / acute urinary retention / bladder outlet obstruction / benign prostatic hyperplasia / BPH / ThuLEP

Cite this article

Download citation ▾
Nikolay Yu. Kostenkov, Salman Kh. Al-Shukri, Evgeniy S. Nevirovich, Oleg M. Mosiychuk, Igor V. Kuzmin, Ilia N. Tkachuk. Thulium laser enucleation of the prostate in patients with large benign prostate hyperplasia and acute urinary retention. Urology reports (St. - Petersburg), 2023, 13(2): 109-115 DOI:10.17816/uroved501787

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Dobrokachestvennaya giperplaziya predstatel’noi zhelezy. Klinicheskie rekomendatsii Minzdrava RF. 2020 Available from: https://cr.minzdrav.gov.ru/recomend/6._ (In Russ.)

[2]

Доброкачественная гиперплазия предстательной железы. Клинические рекомендации Минздрава РФ. 2020. Режим доступа: https://cr.minzdrav.gov.ru/recomend/6_. Дата обращения: 30.04.2023.

[3]

Gondran-Tellier B, McManus R, Sichez PC, et al. Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter. J Endourol. 2021;35(1):102–108. DOI: 10.1089/end.2020.0704

[4]

Gondran-Tellier B., McManus R., Sichez P.C., et al. Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter // J Endourol. 2021;35(1):102–108. DOI: 10.1089/end.2020.0704

[5]

Shormanov IS, Kulikov SV, Solovyov AS. Features of compensatory and adaptive reactions of the vascular bed of the bladder of elderly and senile men with prostatic hyperplasia. Uro logy reports (St. Petersburg). 2022;12(2):127–135. (In Russ.) DOI: 10.17816/uroved108475

[6]

Шорманов И.С., Куликов С.В., Соловьев А.С. Особенности компенсаторно-адаптационных реакций сосудистого русла мочевого пузыря мужчин пожилого и старческого возраста в условиях гиперплазии предстательной железы // Урологические ведомости. 2022. Т. 12, № 2. C. 127–135. DOI: 10.17816/uroved108475

[7]

Huang LK, Chang YH, Shao IH, et al. Clinical outcome of immediate transurethral surgery for benign prostate obstruction patients with acute urinary retention: more radical resection resulted in better voiding function. J Clin Med. 2019;8(9):1278. DOI: 10.3390/jcm8091278

[8]

Huang L.K., Chang Y.H., Shao I.H., et al. Clinical outcome of immediate transurethral surgery for benign prostate obstruction patients with acute urinary retention: more radical resection resulted in better voiding function // J Clin Med. 2019. Vol. 8, No. 9. P. 1278. DOI: 10.3390/jcm8091278

[9]

McNeill SA, Hargreave TB; Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol. 2004;171(6 Pt 1):2316–2320. DOI: 10.1097/01.ju.0000127743.80759.7a

[10]

McNeill S.A., Hargreave T.B.; Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention // J Urol. 2004. Vol. 171, No. 6 Pt 1. P. 2316–2320. DOI: 10.1097/01.ju.0000127743.80759.7a

[11]

Mavrotas J, Gandhi A, Kalogianni V, et al. Acute urinary retention. Br J Hosp Med (Lond). 2022;83(1):1–8. DOI: 10.12968/hmed.2021.0278

[12]

Mavrotas J., Gandhi A., Kalogianni V., et al. Acute urinary retention // Br J Hosp Med (Lond). 2022. Vol. 83, No. 1. P. 1–8. DOI: 10.12968/hmed.2021.0278

[13]

Kostenkov NY, Al-Shukri SK, Amdiy RE, et al. Thulium laser enucleation of prostate (ThuLEP): efficacy and safety evaluation in patients with a prostate volume more than 80 cm3. Uro logy reports (St. Petersburg). 2022;12(3):211–220. (In Russ.) DOI: 10.17816/uroved110730

[14]

Костенков Н.Ю., Аль-Шукри С.Х., Амдий Р.Э., и др. Тулиевая лазерная энуклеация предстательной железы (ThuLEP): оценка эффективности и безопасности у пациентов с объемом предстательной железы более 80 см3 // Урологические ведомости. 2022. Т. 12, № 3. С. 211–220. DOI 10.17816/uroved110730

[15]

Kostenkov NYu, Nevirovich ES, Gorelik SG, et al. Comparative assessment of the intra- and early postoperative period in patients of elderly and old age after various methods of surgical treatment of large benign prostatic hyperplasia. Consilium Medicum. 2022;24(7):447–450. (In Russ.) DOI: 10.26442/20751753.2022.7.201876

[16]

Костенков Н.Ю., Невирович Е.С., Горелик С.Г., и др. Сравнительная оценка интра- и раннего послеоперационного периода у больных пожилого и старческого возраста после различных методов хирургического лечения доброкачественной гиперплазии предстательной железы больших размеров // Consilium Medicum. 2022. Т. 24, № 7. С. 447–450. DOI: 10.26442/20751753.2022.7.201876

[17]

Bozzini G, Berti L, Maltagliati M, et al. Current evidence of ThuLEP for BPH: A review of literature. Turk J Urol. 2021;47(6): 461–469. DOI: 10.5152/tud.2021.21170

[18]

Bozzini G., Berti L., Maltagliati M., et al. Current evidence of ThuLEP for BPH: A review of literature // Turk J Urol. 2021. Vol. 47, No. 6. P. 461–469. DOI: 10.5152/tud.2021.21170

RIGHTS & PERMISSIONS

Eco-Vector

PDF (924KB)

7

Accesses

0

Citation

Detail

Sections
Recommended

/